Fragility of Evidence for the Efficacy of Anti-Fracture Medications - Top-Institutions - MDSpire

Fragility of Evidence for the Efficacy of Anti-Fracture Medications

  • By

  • Nick Tran

  • Thach S Tran

  • Tuan V Nguyen

  • June 9, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Osteoporosis
    • Bone Metabolism
    • Clinical Trials

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Bone Health
    • Clinical Epidemiology

  • #3

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Bone Biology
    • Clinical Trials
    • Epidemiology

  • #4

    University of Sheffield
    University of Sheffield

    Sheffield, UK

    Key Differentiators

    • Bone Health
    • Clinical Trials
    • Epidemiology

  • #5

    University of Oxford
    University of Oxford

    Oxford, UK

    Key Differentiators

    • Bone Health
    • Clinical Epidemiology
    • Pharmacology

Original Source(s)

Fragility of Evidence for the Efficacy of Anti-Fracture Medications

  • by Nick Tran, Thach S Tran, Tuan V Nguyen

  • June 9, 2025

Related Content

Multimodal Progressive Fusion Model for Predicting Hip Fracture Risk in the Elderly: The MMPro-HIP Approach

Predicting poor response to anti-osteoporosis therapy: a machine learning model integrating clinical and novel biomarker data

An explainable predictive machine learning model of osteopenia for perimenopausal women based on clinical data: a retrospective single-center study